Kiromic Biopharma, Inc. (KRBP)

Number of records: 24
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
26-Aug-24 6:44 PM
View: 
Bersani Pietro
Chief Executive Officer
Director
Kiromic Biopharma, Inc. (KRBP) 26-Aug-24Purchase 988$1.93$1,906.84< 1%
141.34K to 142.33K
26-Aug-24 6:44 PM
View: 
Bersani Pietro
Chief Executive Officer
Director
Kiromic Biopharma, Inc. (KRBP) 23-Aug-24Private Purchase 2,500$2.20$5,500.002%
138.84K to 141.34K
21-Aug-24 4:29 PM
View: 
Hungerford Brian
Chief Financial Officer
Kiromic Biopharma, Inc. (KRBP) 20-Aug-24Purchase 3,742$2.20$8,221.176%
61.19K to 64.93K
21-Aug-24 4:29 PM
View: 
Hungerford Brian
Chief Financial Officer
Kiromic Biopharma, Inc. (KRBP) 19-Aug-24Private Purchase 258$2.25$580.50< 1%
60.93K to 61.19K
14-Aug-24 5:03 PM
View: 
Hungerford Brian
Chief Financial Officer
Kiromic Biopharma, Inc. (KRBP) 13-Aug-24Private Purchase 2,000$1.75$3,500.003%
58.93K to 60.93K
13-Jun-24 4:30 PM
View: 
Hungerford Brian
CFO
Kiromic Biopharma, Inc. (KRBP) 13-Jun-24Private Purchase 1,000$2.60$2,600.002%
57.93K to 58.93K
12-Jun-24 4:36 PM
View: 
Hungerford Brian
CFO
Kiromic Biopharma, Inc. (KRBP) 12-Jun-24Market Purchase 1,000$3.18$3,180.002%
56.93K to 57.93K
2%
13-Jun-24 6:32 PM
View: 
Misajon Pamela
Director
Kiromic Biopharma, Inc. (KRBP) 12-Jun-24Market Purchase 1,610$3.28$5,288.406%
27.2K to 28.81K
(2%)
12-Jun-24 4:35 PM
View: 
Bersani Pietro
CEO
Director
Kiromic Biopharma, Inc. (KRBP) 12-Jun-24Market Purchase 3,000$3.28$9,840.002%
135.84K to 138.84K
(2%)
12-Jun-24 4:37 PM
View: 
Nagel Michael
Director
Kiromic Biopharma, Inc. (KRBP) 11-Jun-24Market Purchase 1,000$3.33$3,330.002%
42.3K to 43.3K
(3%)
12-Jun-24 4:35 PM
View: 
Bersani Pietro
CEO
Director
Kiromic Biopharma, Inc. (KRBP) 11-Jun-24Market Purchase 3,000$3.23$9,690.002%
132.84K to 135.84K
0%
12-Jun-24 4:36 PM
View: 
Misajon Pamela
Director
Kiromic Biopharma, Inc. (KRBP) 10-Jun-24Private Purchase 1,701$2.93$4,983.937%
25.5K to 27.2K
07-May-24 6:17 PM
View: 
Hungerford Brian
CFO
Kiromic Biopharma, Inc. (KRBP) 03-May-24Grant 56,933----100%
0 to 56.93K
07-May-24 5:00 PM
View: 
Bersani Pietro
CEO
Director
Kiromic Biopharma, Inc. (KRBP) 03-May-24Grant 45,968----100%
0 to 45.97K
20-Mar-24 5:57 PM
View: 
Misajon Pamela
Director
Kiromic Biopharma, Inc. (KRBP) 18-Mar-24Grant 18,000----240%
7.5K to 25.5K
20-Mar-24 5:58 PM
View: 
Catlin Michael
Director
Kiromic Biopharma, Inc. (KRBP) 18-Mar-24Grant 18,000----240%
7.5K to 25.5K
20-Mar-24 5:55 PM
View: 
Nagel Michael
Director
Kiromic Biopharma, Inc. (KRBP) 18-Mar-24Grant 18,000----74%
24.3K to 42.3K
15-Aug-22 4:26 PM
View: 
Clark Daniel Grant
Chief Financial Officer
Kiromic Biopharma, Inc. (KRBP) 11-Aug-22Grant 50,000----392%
12.77K to 62.77K
15-Aug-22 4:31 PM
View: 
Dahlbeck Scott
Chief of Staff
Kiromic Biopharma, Inc. (KRBP) 11-Aug-22Grant 50,000----11%
446.76K to 496.76K
15-Aug-22 4:23 PM
View: 
Bersani Pietro
Chief Executive Officer
Director
Kiromic Biopharma, Inc. (KRBP) 11-Aug-22Grant 638,298----100%
0 to 638.3K
25-May-22 4:15 PM
View: 
Dahlbeck Scott
Chief Medical Officer
Kiromic Biopharma, Inc. (KRBP) 23-May-22Option Exercise 17,240----4%
429.52K to 446.76K
10-Sep-21 11:47 AM
View: 
Chiriva Internati Maurizio
CHIEF EXECUTIVE OFFICER
Director
Kiromic Biopharma, Inc. (KRBP) 09-Sep-21Market Purchase 2,800$3.70$10,357.20< 1%
1.38M to 1.38M
(< 1%)
02-Aug-21 3:05 PM
View: 
Ryan Michael Charles
See Remarks
Kiromic Biopharma, Inc. (KRBP) 13-Jul-21Acquisition (other) 50,189----100%
0 to 50.19K
26-May-21 3:12 PM
View: 
Schneider Jerry A.
Director
Kiromic Biopharma, Inc. (KRBP) 24-May-21Market Purchase 5,000$7.31$36,550.00100%
0 to 5.0K
7%